AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
POMALIDOMIDE
21 registrations across 4 African markets— 21 active
Markets with POMALIDOMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| IPOPRIN 4 Capsule | 🇰🇪Kenya | MSN Laboratories Private Limited | active | Jul 2030 |
| POMALIDOMIDE 1 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jul 2028 |
| POMALIDOMIDE 4 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jul 2028 |
| POMALIDOMIDE 3 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jul 2028 |
| POMALIDOMIDE 2 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jul 2028 |
| POMAXEL 2 mg | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jul 2028 |
| POMAXEL 1 mg | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jul 2028 |
| POMAXEL 3 mg | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jul 2028 |
| POMAXEL 4 mg | 🇿🇦South Africa | Eurolab (Pty) Ltd | active | Jul 2028 |
| POMYLO 4 mg | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMYLO 3 mg | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMALIDOMIDE 3 mg FORRESTER | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMALIDOMIDE 2 mg FORRESTER | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMALIDOMIDE 4 mg FORRESTER | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMALIDOMIDE 1 mg FORRESTER | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMYLO 1 mg | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| POMYLO 2 mg | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | Jun 2028 |
| IPOPRIN 2 CAPSULE | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Dec 2027 |
| IPOPRIN 4 CAPSULE | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Dec 2027 |
| AMPOMY 2 Capsules | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
| AMPOMY 4 capsule | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
POMALIDOMIDE in Africa — Regulatory Overview
POMALIDOMIDE is registered across 4 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania, Zimbabwe, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 21 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.